François Donat

Efficacy of a Synthetic Pentasaccharide, a Pure Factor Xa Inhibitor, as an Antithrombotic Agent – A Pilot Study in the Setting of Coronary Angioplasty

Alain Vuillemenot, François Schiele, François Donat et al. · Thrombosis and Haemostasis · 1999 · 73 citations

Medicine, Cardiology, Pharmacology +16

Two sensitive and rapid chromogenic assays of fondaparinux sodium (Arixtra) in human plasma and other biological matrices.

F Paolucci, H Frasa, Van Aarle F et al. · PubMed · 2003 · 32 citations

Medicine, Pharmacokinetics, Pharmacology +15

Pharmacokinetics and Effect of Ticlopidine on Platelet Aggregation in Subjects with Normal and Impaired Renal Function

Tom Buur, Rutger Larsson, Ulf Berglund et al. · The Journal of Clinical Pharmacology · 1997 · 23 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacology +13

Safety, Tolerability, and Pharmacokinetics of SR 49059, a V1A Vasopressin Receptor Antagonist, After Repeated Oral Administration in Healthy Volunteers

R. Brouard, Vincent Laporte, C. Serradeil Le Gal et al. · Advances in experimental medicine and biology · 1998 · 19 citations

Medicine, Pharmacokinetics, Pharmacology +5

A pharmacodynamic study of SR 47436, a selective AT₁ receptor antagonist, on blood pressure in conscious cynomolgus monkeys

Alain Roccon, David Marchionni, François Donat et al. · British Journal of Pharmacology · 1994 · 16 citations · Full text

Medicine, Pharmacology, Physiology +16